Tina Ken Schramm

Summary

Affiliation: Bispebjerg University Hospital
Country: Denmark

Publications

  1. doi request reprint Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people
    Tina Ken Schramm
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, DK 2900, Hellerup, Denmark
    Circulation 117:1945-54. 2008
  2. pmc Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006
    Mette L Norgaard
    Department of Cardiology, University Hospital of Copenhagen, Gentofte, Denmark
    Cardiovasc Diabetol 10:5. 2011
  3. pmc Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study
    Casper H Jørgensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Cardiovasc Diabetol 9:54. 2010
  4. doi request reprint Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
    Tina Ken Schramm
    Department of Cardiology B, section 2141, Rigshospitalet, The Heart Center, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Eur Heart J 32:1900-8. 2011
  5. doi request reprint Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Copenhagen, Denmark
    Cardiology 112:144-50. 2009
  6. doi request reprint The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Pharmacoepidemiol Drug Saf 17:822-33. 2008
  7. doi request reprint Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circ Heart Fail 2:582-90. 2009
  8. doi request reprint Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circ Cardiovasc Qual Outcomes 3:395-405. 2010
  9. ncbi request reprint Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, DK 2900 Hellerup, Denmark
    Circulation 113:2906-13. 2006
  10. doi request reprint Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Hellerup, Copenhagen DK 2900, Denmark
    Europace 11:886-91. 2009

Collaborators

Detail Information

Publications15

  1. doi request reprint Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people
    Tina Ken Schramm
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, DK 2900, Hellerup, Denmark
    Circulation 117:1945-54. 2008
    ..Previous studies reveal major differences in the estimated cardiovascular risk in diabetes mellitus, including uncertainty about the risk in young patients. Therefore, large studies of well-defined populations are needed...
  2. pmc Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006
    Mette L Norgaard
    Department of Cardiology, University Hospital of Copenhagen, Gentofte, Denmark
    Cardiovasc Diabetol 10:5. 2011
    ..The aim of the study was to investigate temporal trends in the initiation of GLM among patients discharged after first-time MI...
  3. pmc Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study
    Casper H Jørgensen
    Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Cardiovasc Diabetol 9:54. 2010
    ....
  4. doi request reprint Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
    Tina Ken Schramm
    Department of Cardiology B, section 2141, Rigshospitalet, The Heart Center, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark
    Eur Heart J 32:1900-8. 2011
    ..We examined mortality and cardiovascular risk associated with all available ISs compared with metformin in a nationwide study...
  5. doi request reprint Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Copenhagen, Denmark
    Cardiology 112:144-50. 2009
    ..To study differences in the clinical efficacy of various brands of beta-blocker in secondary prevention after a myocardial infarction (MI)...
  6. doi request reprint The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Pharmacoepidemiol Drug Saf 17:822-33. 2008
    ..To describe the nationwide pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in the Danish population...
  7. doi request reprint Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circ Heart Fail 2:582-90. 2009
    ..Guidelines recommend use of selective serotonin reuptake inhibitors (SSRIs), but knowledge of the prognostic effect of different classes of antidepressants is sparse...
  8. doi request reprint Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals
    Emil Loldrup Fosbøl
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circ Cardiovasc Qual Outcomes 3:395-405. 2010
    ..Studies have raised concern on the cardiovascular safety of nonsteroidal antiinflammatory drugs (NSAIDs). We studied safety of NSAID therapy in a nationwide cohort of healthy individuals...
  9. ncbi request reprint Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, DK 2900 Hellerup, Denmark
    Circulation 113:2906-13. 2006
    ..We analyzed the risk of rehospitalization for acute myocardial infarction (MI) and death related to the use of NSAIDs including selective COX-2 inhibitors in patients with prior MI...
  10. doi request reprint Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide study
    Søren Skøtt Andersen
    Department of Cardiology, Gentofte University Hospital, Niels Andersens Vej 65, Hellerup, Copenhagen DK 2900, Denmark
    Europace 11:886-91. 2009
    ..To examine the risk of death associated with antiarrhythmic drug (AAD) therapy in a nationwide unselected cohort of patients with atrial fibrillation (AF)...
  11. pmc Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study
    Ditte Marie Bretler
    Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, Hellerup, Denmark
    Br J Clin Pharmacol 71:105-15. 2011
    ..HRT is not recommended for primary or secondary prevention of coronary heart disease and guidelines recommend discontinuation of HRT after myocardial infarction (MI). It is unknown whether women actually discontinue HRT after MI...
  12. doi request reprint Location of cardiac arrest in a city center: strategic placement of automated external defibrillators in public locations
    Fredrik Folke
    Research Fellow, Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark, Niels Andersens Vej 65, 2900 Hellerup, Denmark
    Circulation 120:510-7. 2009
    ..The potential benefit and economic consequences of focused or unfocused AED deployment are unknown...
  13. ncbi request reprint Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes
    Gunnar H Gislason
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Circulation 116:737-44. 2007
    ..We studied initiation and persistence of evidence-based pharmacotherapy in 107,092 patients discharged after first hospitalization for heart failure in Denmark from 1995 to 2004...
  14. doi request reprint Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study
    Lisbeth Bonde
    Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    J Am Coll Cardiol 55:1300-7. 2010
    ..We studied the association of clopidogrel with mortality in acute myocardial infarction (AMI) patients with heart failure (HF) not receiving percutaneous coronary intervention (PCI)...
  15. pmc Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after myocardial infarction
    Morten L Hansen
    Department of Cardiovascular Medicine, Bispebjerg University Hospital, Copenhagen, Denmark
    Br J Clin Pharmacol 65:217-23. 2008
    ..Therefore, for long-term benefits for patients who need treatment with an ACE inhibitor, a focus of treatment at the recommended dosage is most important and not which ACE inhibitor is used...